Insulet Enrolls First Participant In Pivotal Study For Fully Closed-Loop Automated Insulin Delivery System For Type 2 Diabetes
First participant enrolled in randomized control trial designed to demonstrate safety and efficacy of Insulet's fully closed-loop automated insulin delivery system versus standard therapyUnique algorithm automatically

































